Stueland Katherine sold WGS
December 16, 2025 · Form 4 insider transaction
Stueland Katherine sold 74 shares of GeneDx Holdings Corp. at $150.75 per share, a transaction worth $11.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
74
Price
$150.75
Total value
$11.2K
InsiderStueland Katherine
RoleOfficer, Director
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateDecember 16, 2025
Filing dateDecember 18, 2025
Shares owned after14,593
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.